In contrast to α-PD-1 monotherapy (Figs. 2a), α-TGFβ antibodies or the drug combination resulted in infiltration of total CD45+ and CD8a + T cells into the tumor core (Fig. 4a). Here, TGFB1 is linked to neoplasm.